Compounded Semaglutide Cost Savings

Compounded semaglutide is a version of the drug created by a compounding pharmacy. They take the active pharmaceutical ingredient (API) and mix it into a custom formulation, often in a liquid form for injection. This is typically done when there is a shortage of the brand-name drug (Ozempic/Wegovy) or when a patient needs a custom dose or preservative-free version.

Compounded medications are not FDA-approved in the same way brand-name drugs are. The safety and efficacy depend entirely on the compounding pharmacy's quality standards. It is critical to use a pharmacy that is PCAB-accredited and provides a Certificate of Analysis (CoA) for each batch of API to ensure purity and correct concentration.

The cost difference is primarily due to the lack of expensive branding, marketing, and the same rigorous (and costly) FDA approval process for every single batch. Compounding pharmacies sell the drug at a price closer to the cost of the raw API plus a service fee, whereas brand-name manufacturers charge a premium for the approved delivery system (the pen) and brand equity.

Generally, no. Most insurance companies only cover FDA-approved brand-name medications. Compounded versions are almost always "out-of-pocket" expenses. However, for many users, the compounded cost is still significantly lower than the brand-name copay after a high deductible.